NCT02860676 2025-12-15
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
University of California, San Diego
Phase 1 Completed
Clinical Trials
4 trialsNCT04501939 2025-09-02
Venetoclax
University of California, San Diego
Phase 2 Active not recruiting
NCT05431179 2023-04-21
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Oncternal Therapeutics, Inc
Phase 3 Withdrawn
NCT02222688 2020-08-13
UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia
University of California, San Diego
Phase 1 Completed